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PURPOSE. The goal of this study was to determine if continuous application of insulin-like
growth factor-1 (IGF-1) could improve eye alignment of adult strabismic nonhuman primates
and to assess possible mechanisms of effect.
METHODS. A continuous release pellet of IGF-1 was placed on one medial rectus muscle in two
adult nonhuman primates (M1, M2) rendered exotropic by the alternating monocular
occlusion method during the first months of life. Eye alignment and eye movements were
recorded for 3 months, after which M1 was euthanized, and the lateral and medial rectus
muscles were removed for morphometric analysis of fiber size, nerve, and neuromuscular
density.
RESULTS. Monkey 1 showed a 40% reduction in strabismus angle, a reduction of exotropia of
approximately 118 to 148 after 3 months. Monkey 2 showed a 15% improvement, with a
reduction of its exotropia by approximately 38. The treated medial rectus muscle of M1
showed increased mean myofiber cross-sectional areas. Increases in myofiber size also were
seen in the contralateral medial rectus and lateral rectus muscles. Similarly, nerve density
increased in the contralateral medial rectus and yoked lateral rectus.
CONCLUSIONS. This study demonstrates that in adult nonhuman primates with a sensory-
induced exotropia in infancy, continuous IGF-1 treatment improves eye alignment, resulting
in muscle fiber enlargement and altered innervational density that includes the untreated
muscles. This supports the view that there is sufficient plasticity in the adult ocular motor
system to allow continuous IGF-1 treatment over months to produce improvement in eye
alignment in early-onset strabismus.
Keywords: insulin growth factor-1, myogenic growth factors, eye movements, extraocular
muscles, strabismus, innervation, smooth pursuit, neuromuscular junctions
Strabismus has been treated in much the same way for morethan 100 years.1 If patching and/or spectacle wear fails to
restore normal eye alignment, strabismus surgery is the next
treatment approach. This involves surgical manipulation of the
extraocular muscle (EOM) insertions on the sclera. However,
20% to 50% of such surgeries fail to produce good alignment
(defined as residual misalignment of <10 prism diopters).2–6
Long-term failure rates for strabismus surgery are even higher;
in one study, the 10- and 20-year failure rate was 51% and 66%,
respectively, defined as those subjects requiring a second
surgery.7 In a second study, failure rates were 86% by 15 years.8
These longitudinal studies suggest that surgical correction of
eye position does not adequately address the underlying cause
of the misalignment, which, in turn, drives return of the
strabismus.
One possible explanation is that the visual system may be
unable to adapt to abrupt changes in alignment produced by
surgery. As a consequence, other visual or oculomotor adaptive
processes act to gradually return the eyes to the presurgical
state of misalignment. If this is the case, then more gradual and
sustained treatment that potentiates muscle and nervous
system plasticity may offer a solution. This hypothesis forms
the basis of the present experiment.
Insulin-like growth factor (IGF-1) is a neurotrophic factor
known to have a role in muscle growth during development
and regeneration.9,10 It is able to increase muscle size and
improve function when upregulated in the muscles of mouse
models of muscular dystrophy and in sarcopenia associated
with aging.11,12 In a series of studies in adult rabbit EOMs, we
demonstrated that single injections and sustained delivery of
IGF-1 resulted in significant increases in the size and force
generation in the treated rectus muscles.13,14 After single
injections in chicks15 and sustained delivery in infant mon-
keys,16,17 IGF-1 treatment also resulted in larger myofibers.
These results suggested that sustained delivery of IGF-1 has
potential as an effective long-term treatment for strabismus.
Sustained delivery of IGF-1, and the potential slow and gradual
changes associated with such delivery, would avoid the large
single change in eye alignment often associated with surgical
intervention and, therefore, allow plasticity mechanisms in the
iovs.arvojournals.org j ISSN: 1552-5783 6070
This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/935850/ on 10/11/2018
visual system and/or ocular motor system to adapt to the
change in eye alignment.18–21 This conceptually has interesting
implications for strabismus treatment, and experimental animal
models allow this to be studied in more detail.
As a proof of concept, two adult macaque monkeys at age 6
years, made exotropic using the alternating monocular
occlusion method in infancy,22,23 were implanted with
sustained release IGF-1 pellets unilaterally. Fixation and smooth
pursuit movements were assessed periodically for 3 months. At
the end of the 3-month period, which is the duration of IGF-1
release from the implanted pellets, the horizontal extraocular
muscles of one monkey (M1) were examined morphometri-
cally for changes in myofiber size and density of innervation.
Despite their long-term strabismus, both monkeys showed
improvement in eye alignment. While the improvement of M1
was superior to the result in the second monkey, this study
demonstrated that sustained release of neurotrophic factors
can alter eye alignment bilaterally in adult strabismus after a
unilateral treatment, even when the strabismus was induced by
sensory deprivation in infancy.
METHODS
Animals and Surgery for Sustained IGF-1
Treatment
All studies were approved by the animal care and use
committees at Emory University and the University of
Minnesota, and all experiments adhered to the National
Institutes of Health (NIH; Bethesda, MD, USA) Animal Care
and Use Guidelines and ARVO Guidelines for Use of Animals in
Ophthalmic and Vision Research. Adult monkeys were used as
the source of experimental data and for all the tissues analyzed
in this study.
Within the first 24 hours after birth, two infant monkeys
(Macaca mulatta; M1, M2) were treated daily with an opaque
contact lens placed on one eye for 24 hours, switched to the
fellow eye for the next 24 hours, and this patching was
alternated on a daily basis for a period of 4 months. The
patched infant monkeys were monitored 8 to 12 times per day
every day to ensure that the contact lens remained in place.
The lack of binocular input produced exotropia in both
monkeys, and both were alternating monocular fixators. At
approximately 3 years of age, the monkeys were implanted
with a head stabilization post and scleral search coils in each
eye for precise eye movement measurement. All surgeries were
performed using sterile technique under isoflurane anesthesia
(1.25%–2.5%).
The animals were trained to perform standard eye
movement tasks, including fixating stationary visual targets at
known eccentricities, visually guided saccades, and smooth
pursuit of moving targets (6108–208; 0.25–0.5 Hz) projected
on a tangent screen. At the end of these experiments,
approximately, 6 to 8 years, the monkeys were selected for
IGF-1 treatment. Under general anesthesia using standard
sterile technique, an incision was made in the medial
conjunctiva, and after visualization of the medial rectus
muscles, a 3 3 1.5-mm pellet prepared to release 1 lg/d of
IGF-1 for a total of 90 days (Innovative Research of America,
Sarasota, FL, USA) was implanted on the orbital side of a single
medial rectus muscle in each monkey. This dose was selected
based upon previous studies.13 After pellet implantation, the
conjunctiva was closed with an 8-0 polyglactin suture. At 2
months after pellet implantation, verification of pellet position
in the first monkey was performed by magnetic resonance
imaging (MRI; axial sequence; 3T Siemens Trio 3-Tesla
magnetic resonance imager, T1-weighted fast spin-echo; Sie-
mens, Munich, Germany).
To examine the effect of IGF-1 on alignment and eye
movements, binocular eye and target data were collected as
the animals performed a fixation task – fixating a series of
targets along the horizontal or vertical meridian, and a smooth-
pursuit task – tracking of sinusoidal motion of target (0.3 Hz 6
108–158) along the horizontal plane under monocular, right
eye, or left eye viewing conditions. Binocular eye position was
measured using the magnetic search coil technique (Angle-
Meter; Primelec Industries, Regensdorf, Switzerland) as de-
scribed previously.23 This system provides precise and reliable
measurement of eye position to a resolution better than 0.58.
Eye coil signals were calibrated under monocular viewing
conditions by rewarding the monkey for looking within a 28 to
38 window surrounding a 18 target that was rear projected on a
tangent screen 60 cm away from the animal. Visual stimuli
were generated under computer control using a VSG2/5 visual
stimulus generator installed in a Windows PC (Cambridge
Research Systems Ltd, Rochester, England). Binocular eye and
target position feedback signals were processed with anti-
aliasing filters at 400 Hz before digitization at 1 KHz with 16-bit
precision (Data Acquisition boards and Labview software;
National Instruments, Austin, TX, USA). Data analysis was
performed with custom software routines written in Matlab
(Mathworks, Natick, MA, USA) and involved examining
alignment of the eyes during fixation and smooth pursuit eye
movements.
At the end of 3 months, M1 was deeply anesthetized,
followed by euthanasia performed by a licensed veterinarian.
All medial and lateral rectus muscles were dissected in their
entirety from origin to insertion, embedded in tragacanth gum
and rapidly frozen in 2-methylbutane chilled to a slurry on
liquid nitrogen. The muscles were stored at808C. In addition,
three sets of na¨ıve control EOM were processed similarly.
These muscles were collected after euthanasia from 3 adult
monkeys (M. mulatta) that had been used for nonrelated
studies at the University of Minnesota. None of these animals
had strabismus nor were subjected to EOM manipulations or
treatments. Previous studies showed that there were no
measurable changes in the vertical muscles, so they were not
analyzed for the present study.16,17
Muscles were sectioned at 12 lm using a Leica cryostat
(Leica; Wetzlar, Germany), and the slides were air-dried and
then stored at 808C until processed. Every 20th slide was
stained with hematoxylin and eosin. A second set was
immunostained for the fast myosin heavy chain isoform
(1:20; Vector Laboratories, Burlingame, CA, USA), neurofila-
ment protein (smi-31, 1:1000; Covance, Princeton, NJ, USA), or
for the neuromuscular junction using a-bungarotoxin labeled
with Alexa Fluor 488 (1:3000; Molecular Probes, Eugene, OR,
USA). For mean cross-sectional area, a minimum of 3 slides
from the mid belly region and 3 slides toward the tendon end
were analyzed, with a minimum of 200 myofibers measured
per slide from the orbital and global layers. For nerve density,
again 3 sections from the tendon and mid belly regions were
analyzed for nerve density as a percentage of overall muscle
area using the Bioquant Morphometry System (Bioquant,
Nashville, TN, USA) as described previously.17 Briefly, nerves
and total area were quantified from a minimum of 3 fields in
orbital and global layers in the mid belly and tendon regions to
yield density of nerves per cross-sectional area. Neuromuscular
junction density was determined similarly, and reported as
number per cross-sectional area. Sizes of neuromuscular
junctions also were determined in control and IGF-1–treated
medial rectus muscles, either as area or length, and then
analyzed relative to myofiber area or perimeter, respectively. All
neuromuscular junctions on 3 cross-sections were photo-
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graphed, and measured using the Bioquant system. The large
number of myofibers and neuromuscular junctions examined
allowed the use of a 1-way ANOVA followed by a Tukey’s
multiple comparison post hoc test to determine significance,
where P < 0.05. Data are presented at mean 6 SEM.
RESULTS
At the time of pellet implantation, both monkeys were
exotropic. Pellet location was confirmed with MRI in M1
(Fig. 1). The pellet in M2 could not be definitely identified on
the muscle with MRI at 2 months. The initial angle of
misalignment of M1 was approximately 288 with the right
eye viewing and approximately 258 with the left eye viewing
(Fig. 2A). During the first 2 months of pellet treatment, the
angle of misalignment changed very slightly, from 288 to 248 in
M1 (Fig. 2A). At the end of the third month, M1 showed a large
improvement in eye alignment; the strabismic angle changed
to 188 in the right eye, an improvement of 108, and to 148 in the
left eye, an improvement of 118 (Fig. 2). This represents an
improvement in strabismic angle of 35.7% and 44%, respec-
tively. This also can be seen on the smooth pursuit data (Fig.
2B). It should be noted that these changes occurred bilaterally,
despite only one medial rectus muscle being treated.
For M2 the initial angle of misalignment was approximately
12.508 with the right eye viewing and approximately 198 with
the left eye viewing (Fig. 3). Monkey 2 also showed an
improvement in eye alignment, 2.58 in the right eye and 38 in
the left eye (Fig. 3). This represents an improvement in
strabismic angle of 20% and 15.8%, respectively. The MRI at 2
months could not locate the pellet placement definitively, and
this may explain the differential in effectiveness seen between
the two treated monkeys.
To better understand the structural changes that caused this
change in eye alignment, mean cross-sectional areas of the
EOM were determined for M1. The mean myofiber cross-
sectional area of the treated muscle was consistently larger
than the na¨ıve control muscles (Fig. 4). For the midbelly
region, after the 3 months of sustained IGF-1 treatment the
orbital layer fibers were 57.8% larger than control, at 427.61 6
35.4 lm2 compared to 270.99 6 15.25 lm2, and the global
layer fibers were 11% larger than control myofibers, 1272.96 6
101.95 lm2 compared to 1151.32 6 64.48 lm2 (Fig. 4A).
Differences were similar in the tendon region, which was
closer to the pellet. The mean cross-sectional areas for the
treated orbital fibers in the tendon region were 13.4% larger,
272.84 6 24.74 lm2 compared to the treated muscle at 328.88
6 17.09 lm2, and the treated global fibers were 19% larger,
1003.45 6 74.88 lm2 compared to 844.46 6 64.64 lm2 (Fig.
4A). The contralateral untreated medial rectus also showed an
increase in mean myofiber cross-sectional areas, particularly in
the tendon region. The mean cross-sectional areas of the
untreated medial rectus muscle on the contralateral side were
27% and 41% larger in the orbital and global layers in the mid
belly region than control areas, and 60% and 82% larger in the
orbital and global layers in the tendon region compared to
control values. Additionally there were changes in the yoked
lateral rectus muscle of the contralateral orbit, with increases
in the middle region of 58% and 44%, and increases in the
tendon region of 71% and 18% for the orbital and global layers
respectively. Similarly, changes were seen in the lateral rectus
muscle ipsilateral to the treated medial rectus muscle. These
types of increases were seen in the untreated muscles of infant
FIGURE 1. Magnetic resonance imaging (MRI) of M1 at 2 months
showing the pellet in place on the medial rectus muscle (arrow)
performed using a Siemens 3-T imager, T1-weighted fast spin-echo.
FIGURE 2. (A) Eye alignment of M1 showing the slow improvement in
eye alignment over the first 2 months, and a large change in strabismus
angle during month 3 of continuous IGF-1 treatment. (B) Smooth
pursuit movements in M1 showing the improvement in eye alignment
between the initial time point and after 3 months of IGF-1 treatment.
Red represents the position of the right eye, blue the position of the
left eye, and black represents the target position; þve values indicate
rightward eye positions and –ve values are leftward eye positions.
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monkeys made strabismic after 3 months of unilateral IGF-117
or GDNF treatment (McLoon L, et al. IOVS 2016;57:ARVO E-
Abstract 1395). Note that the lateral rectus myofibers were
significantly smaller than the medial rectus myofibers in the
control monkeys.
Insulin-like growth factor-1 has multiple actions in skeletal
muscle. In addition to causing myofiber hypertrophy, it also
can increase nerve outgrowth.24,25 Using an antibody to
neurofilament protein, the overall density of nerve fibers was
assessed based on total cross-sectional area (Figs. 5, 6). There
was a pronounced increase in nerve fiber density in the treated
medial rectus muscle compared to control specimens (Figs. 5,
6A). In the midregion of the muscles, the treated muscle nerve
density was 55% greater, 8.25 6 0.81 compared to 5.33 6 0.16
lm2. In the tendon region, there was a 192% increase in nerve
density, 3.1 6 0.48 lm2 compared to the control at 1.06 6
0.12 lm2. In the untreated, contralateral medial rectus, there
was a large increase in nerve density compared to the control
muscles, with increases of 108% in the midregion and 158% in
the region near the tendon. This represents, respectively, an
increase of 34% and a decrease of 11% in the middle and
tendon regions compared to the treated medial rectus muscle.
Increases in the innervation of the yoked lateral rectus muscle
also were seen.
An increase in nerve density should translate into changes
in neuromuscular junction density or size. Interestingly,
analysis showed that there was a 31% lower density of
neuromuscular junctions in the treated compared to the
control medial rectus muscles, 0.00007586 6 0.00005/lm2
compared to control at 0.001094 6 0.0002/lm2, but a very
large 52% increase in the density of the neuromuscular
junctions in the contralateral medial rectus muscle at a density
of 0.00166 6 0.0002/lm2 (Fig. 7). In addition, compared to
normal control lateral rectus muscles, there was approximately
a 25% to 57% increase in neuromuscular junction density in the
yoked and ipsilateral lateral rectus muscles.
Neuromuscular junction length (lm) and area (lm2) were
assessed in control medial and lateral rectus muscles, and in all
four of the horizontal rectus muscles in M1 (Fig. 8). There were
no alterations in the mean neuromuscular junction length in
any of the muscles examined. However, there was a large 168%
increase in the mean neuromuscular junction area in the
treated medial rectus muscle compared to controls, an increase
of 60% in the contralateral medial rectus muscle, and an
increase of 163% in the yoked lateral rectus muscle (Fig. 8A).
As mean fiber size was altered by the IGF-1 treatment,
neuromuscular junction size was reanalyzed either as length
as a proportion of myofiber perimeter or area as a proportion
of myofiber area (Fig. 8B). In all the muscles analyzed from M1,
the ratio of neuromuscular junction length to myofiber
perimeter was decreased compared to control muscles, from
37% for the treated medial rectus muscle to 18% to 22% for the
medial and lateral rectus muscles in the contralateral orbit (Fig.
8B). This analysis demonstrated that relative to fiber perimeter,
the neuromuscular junctions in horizontal muscles of the IGF-1
treated monkey were 20% to 26% smaller than controls. In
summary, IGF-1 treatment in the adult strabismic monkey
resulted in an increased density of neuromuscular junctions,
but they were proportionally smaller than those in age-
matched control medial rectus muscles.
DISCUSSION
Three months of sustained release treatment with IGF-1
adjacent to a single medial rectus muscle improved the eye
FIGURE 3. Eye alignment of M2 showing change in eye alignment from 1 week after implant and 3 months after the start of the IGF-1 treatment
period. Red represents the position of the right eye and blue the position of the left eye.
FIGURE 4. (A) Mean cross-sectional areas of the medial rectus muscles
from controls and M1 after the 3-month IGF-1 treatment period. (B) Mean
cross-sectional areas of the lateral rectus muscles from controls and M1
after the 3-month IGF-1 treatment period. *Significant difference from
na¨ıve control myofiber population in the same layer and muscle region.
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alignment of adult nonhuman primates with a sensory-induced
exotropia created in infancy. Myofiber hypertrophy is a known
effect of IGF-1 treatment, particularly when it is maintained
over time as was done in the present study.10,12,26 In M1,
which had the most significant improvement in eye alignment,
the mean cross-sectional areas of the treated myofibers were
enlarged by 11% to 58% in the midbelly region and 13% to 19%
in the tendon region compared to age-matched control medial
rectus muscles. Despite only treating one medial rectus
muscle, increased mean cross-sectional areas also were evident
in the medial rectus muscle in the contralateral orbit, with
increases of 27% and 41% in the mid belly region and 60% to
82% in the tendon region. Similarly there were increases in
mean myofibers areas in the functionally yoked lateral rectus
muscle. It is interesting that the largest increases in myofiber
area were in the untreated medial rectus on the contralateral
side. This suggested that part of the bilateral improvement in
eye alignment after unilateral IGF-1 treatment is related to the
ability of the oculomotor system to estimate muscle size and
force production, and drive compensation of the muscles
bilaterally. Our previous work demonstrated that unilateral, but
not bilateral, medial rectus muscle treatment with IGF-1 in
infant primates was required to produce a strabismus also
suggesting central nervous system control of these changes.17
There was increased nerve density as a result of the IGF-1
treatment, another well described function of muscle-derived
IGF-1.24,25 Insulin-like growth factor-1 has been shown to
cause increased axon number, size, and density when locally
delivered.27 Thus, the increased nerve density in the treated
medial rectus muscle was expected. It is noteworthy that there
was significant nerve growth into the untreated medial rectus
muscle in the contralateral orbit; this type of change in
untreated muscles is a common feature of unilateral treatments
of the EOM.28,29 There also was increased nerve density in the
contralateral lateral rectus muscle. Such coordinated adapta-
tions of untreated muscles that are contralateral to a given
treatment have been described in the exercise physiology
literature. Resistance exercise has been shown to result in
FIGURE 5. Immunostaining for neurofilament protein (smi-31) in controls and M1 in (A) an aged-matched control monkey medial rectus muscle, (B)
the treated medial rectus muscle, and (C) the yoked lateral rectus muscle in the contralateral orbit. Arrows indicate nerves within the muscles. Scale
bar: 50 lm.
FIGURE 6. Quantification of nerve density in controls and M1 in the middle of the muscle and in the tendon region (A) in the medial rectus muscles and
in the (B) lateral rectus muscles. Ten, tendon; mid, mid region; contra, contralateral; ipsi, ipsilateral. *Significant difference from na¨ıve control muscles.
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FIGURE 7. Visualization of the neuromuscular junctions with fluorescently labeled a-bungarotoxin in (A) the control monkey, and in M1 (B) the
treated medial rectus, and (C) the contralateral medial rectus muscle. Arrows indicate neuromuscular junctions. Scale bar: 75 lm. (D)
Quantification of neuromuscular junction density in all medial and lateral rectus muscles in controls and M1. #Significant difference compared to
the treated medial rectus muscle.
FIGURE 8. (A) Average neuromuscular junction (NMJ) length and area. (B) Average size of NMJs calculated as length/fiber perimeter and area/fiber
area in control medial rectus muscles (MR), in the IGF-1–treated MR, contralateral MR, and yoked lateral rectus muscle (LR) in the contralateral
orbit. *Significant difference from na¨ıve control muscles. #Significant difference compared to the treated medial rectus muscle. @Significant
difference between contra LR and contra MR.
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increased expression of IGF-1, demonstrating the effects of
elevated IGF-1 when levels were increased unilaterally.29 For
example, in one study, 4 weeks of unilateral resistance training
resulted in significant increases in muscle strength on the
untrained side.30 In a study in stroke patients, high intensity
unilateral resistance training of one limb resulted in significant
gains in force in the contralateral but nonexercised limb.31
Using a transcranial magnetic stimulation method, unilateral
training protocols were shown to reduce intracortical inhibi-
tion and silent period duration as well as increase corticospinal
excitability.32,33 The physiologic bases for these changes are
not understood, but our data support the view that there is
bidirectional communication between the central brain areas
and yoked and agonist-antagonist muscle pairs. As indicated, it
is important to remember that resistance exercise resulted in
increased muscle expression of IGF-1.34,35 Thus, the unilateral
resistance training was able to induce significant changes of
innervation in the untreated muscles of the contralateral side,
similar to what we observed in the present experiment, at least
in part by an increase in IGF-1.
Nerve density does not necessarily equate to changes in
neuromuscular junction density. However, it is known that IGF-
1 also can cause increased postsynaptic density size and
complexity36 as well as synaptic potentiation.37 This is
interesting in light of the apparent decrease in neuromuscular
junction density in the treated medial rectus muscle, although
it was not significantly different from na¨ıve control neuromus-
cular junction density. There was, however, a very large
increase in neuromuscular junction density in the untreated
medial rectus muscle in the contralateral orbit, which
correlated very well with the significant increase in nerve
density. Neuromuscular junction density was unchanged in the
lateral rectus muscles. In addition to number of neuromuscular
junctions per muscle area, the complexity of neuromuscular
junctions can be affected by IGF-1.36 We calculated the average
size and area of neuromuscular junctions and in addition
determined their size relative to myofiber perimeter and area,
respectively. The average neuromuscular junction area signif-
icantly increased in the treated medial rectus and the
contralateral yoked lateral rectus muscle. However, when
examined relative to myofiber size, the story is more
complicated. There were small decreases in the length of the
neuromuscular junctions in the treated medical rectus muscle
and contralateral lateral rectus muscle in proportion to fiber
perimeter, while the neuromuscular junctions were signifi-
cantly larger in the contralateral medial rectus muscle than in
the treated muscle. This suggested that after 3 months of
adaptation to exogenously applied IGF-1 to a single medial
rectus muscle, there was an increased drive from the
innervating motor neurons of the untreated medial rectus.
The method for communication of single muscle changes
within the brain is not known. At the end of the 3 months of
exogenous IGF-1 treatment, there also appeared to be a
reduced drive from the motor neurons innervating the
hypertrophied treated medial rectus muscle to reduce its
‘‘force’’ by decreasing innervation to this muscle. This
hypothesis correlated with neuronal recordings after resec-
tion/recession surgery, which demonstrated significant chang-
es in neuronal drive 1 to 6 months after surgery correlating
with worsening strabismic angle (Pullela M, et al. IOVS
2015;56:ARVO E-Abstract 5221; Agaoglu MN, et al. IOVS
2015;56:ARVO E-Abstract 5222). In other words, in addition
to moment-by-moment changes in innervation to the untreated
eye that is a normal response to changes in yoked muscle
contractility of the treated eye, there also are longer term
adaptive processes that actually change muscle structural
properties and neuromuscular junction structural properties of
the untreated eye.28,38,39 Both of these factors influenced
misalignment when the subjects viewed with their treated eye.
With respect to synaptic efficacy, it remains to be determined
whether these synaptic changes are accompanied by fine-scale
structural changes within the synapse, such as a change in the
size or efficacy of active zones in the presynaptic ele-
ments.40–42
Insulin-like growth factor-1 has been implicated in restoring
synaptic plasticity in the mature brain, including sensorimotor43
and visual cortex.44 Our observations suggested that sustained
release IGF-1 unilaterally also has a similar potential to modulate
neuromuscular changes at the muscle level, presumably driven
by the oculomotor system at the brainstem level. It has been
demonstrated clearly that brain activity, as opposed to muscle
changes alone, contribute to the control of strabismus
angle.45–47 In cat abducens motor neurons, it also has been
shown that various neurotrophic factors can regulate the firing
patterns and synaptic composition of the motor neurons that
control eye movements.48,49 These studies support the hypoth-
esis that neurotrophic factors are modulating influences on
motor neuron function, and by altering the balance of these
factors one has the potential to alter the balance of eye
alignment/misalignment through communication between ocu-
lomotor and abducens motor neurons within the brainstem. The
bilateral nature of the changes in alignment and EOM structure
in the present study, after unilateral IGF-1 treatment, provides
further support for this view. Previous studies in rabbit showed
that IGF-1 localization was dramatically altered and moved from
the inside of the fiber to its periphery after experimental
strabismus surgery in rabbits.28 This strongly implicates the
potential extracellular release of IGF-1 in myofiber remodeling
and regenerative processes. While our studies of continuous
glial cell line-derived neurotropic factor (GDNF) treatment of
one medial rectus muscle in infants resulted in both induction of
strabismus as well as maintenance of strabismus after treatment
was completed (McLoon L, et al. IOVS 2016;57:ARVO E-Abstract
1395), it remains to be determined whether these improve-
ments to eye alignment after sustained IGF-1 treatment in adult
strabismic monkeys would be maintained. Our study suggests
that targeted and sustained neurotrophic factor therapies, which
leverage inherent oculomotor plasticity mechanisms, have the
potential to augment current surgical approaches to provide
lasting solutions to cure strabismus.
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